Targeted Therapies Partnering & Licensing Summit Asia
Market Access
With fast, cost-effective clinical infrastructure, generous government incentives, and simplified regulatory pathways, Asia’s biotech ecosystem has emerged as a global launchpad for innovation. Western pharma and biotech companies are increasingly turning to de-risked assets from Asia to supercharge their clinical pipelines and gain a competitive edge.
For NewCo, private and public biotech or small pharma, this accessible forum offers:
- High seniority and quality of attendees across pharma and other biotech
- Targeted focus, purpose-built format, and One-on-One Partnering™ portal, allowing you to make meaningful connections easier and more efficiently
- Informative presentations and discussions nuanced to considerations for deal-making across targeted therapies
Secure your place here or get in touch with the team – info@hansonwade.com
